Phenylketonuria Treatment Market (2024 - 2034)
Phenylketonuria Treatment Market Study by Essential & Non-Essential Amino Acids and Glycomacropeptide in Powder, Granules, Tablets, Capsules, Sachets, Ready-to-Drink, and Shakes from 2024 to 2034
Core Findings
FREE CustomizationPhenylketonuria Treatment Market Outlook (2024 to 2034)
Revenue from the global phenylketonuria treatment market is estimated to reach US$ 761.6 million in 2024. The market has been analyzed to climb to a value of US$ 1.62 billion by the end of 2034, expanding at a CAGR of 7.8% over the next ten years.
Amino acids, both essential and non-essential, play a critical role in managing phenylketonuria (PKU), where the inability to convert phenylalanine (Phe) into tyrosine stems from a deficiency of the enzyme phenylalanine hydroxylase.
Individuals with PKU require Phe-free amino acid formulations and must adhere to a low-Phe diet throughout their lives to prevent cognitive impairment. Consequently, there remains a substantial market for amino acid-based nutritional therapies targeting PKU.
Key Market Growth Drivers
- Government initiatives supporting rare disease treatments, including PKU, increase research funding, streamline regulatory approval processes for new therapies, and facilitate market access for innovative treatments.
- Early detection and monitoring of PKU are facilitated by advancements in diagnostic testing technologies like genetic testing and newborn screening programs, driving ongoing demand for treatment options.
- Patient advocacy groups play a crucial role in raising awareness about PKU, advocating for research funding, and supporting affected individuals and their families, which elevates demand for improved treatment options and quality of life standards.
- The rising popularity of personalized medicine approaches in healthcare, including tailored treatments for PKU based on individual genetic profiles, contributes to enhanced treatment outcomes and patient satisfaction.
- Advancements in PKU treatment technologies, such as novel enzyme replacement therapies, gene therapy strategies, and innovative medical food formulations, enhance patient compliance and treatment efficacy, thereby contributing to the expansion of the phenylketonuria treatment market size.
| Report Attribute | Detail |
|---|---|
| Phenylketonuria Treatment Market Size (2024E) | US$ 761.6 Million |
| Projected Market Value (2034F) | US$ 1.62 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.8% CAGR |
| East Asia Market Growth Rate (2024 to 2034) | 8.3% CAGR |
| North America Market Growth Rate (2034) | 6.7% CAGR |
| Revenue from Retail Pharmacies (2024) | US$ 288.6 Million |
| Sales of Powder & Granules (2024) | US$ 371.7 Million |
| Key Companies Profiled | Arla Foods Ingredients Group P/S; Archer Daniels Midland Company; BASF SE; Chr. Hansen; Cargill, Incorporated; Seidler Chemical Co, Inc.; Archer Daniels Midland Company; BASF SE; Chr. Hansen; Cargill, Incorporated; Seidler Chemical Co, Inc.; Nestlé S.A. (Vitaflo International). |
What’s Benefitting Phenylketonuria Treatment Providers?
“Efforts to Scale Up Production Facilities to Meet Growing Market Demands”
Primary treatment approach for PKU patients involves adhering to a low-phenylalanine diet, which restricts dietary protein intake. With a growing demand for innovative formulations to address phenylketonuria, manufacturers are intensifying their focus on research and development efforts. They are also investing in exploring adjunct therapies for PKU treatment and expanding manufacturing capacities to drive significant growth in the phenylketonuria treatment market.
Public awareness campaigns about PKU, spearheaded by local governments, NGOs, and regulatory bodies, aim to educate populations in both developed and developing countries about integrated systems and treatment options. Increasing awareness and adoption of medical foods are anticipated to bolster future market expansion for PKU treatments. Researchers are actively pursuing novel treatments for rare genetic disorders, aiming to optimize outcomes and enhance quality of life, given the rising prevalence of these conditions.
Rising PKU prevalence and limited treatment options are prompting government and private sector investments in the development of advanced, highly efficacious PKU formulations.
How is Market Expansion Being Affected to Some Extent?
“High Cost of Treatment and Strict Adherence to Low-Phenylalanine Diet”
Phenylketonuria (PKU) is typically managed using specialized medical foods and formulas, which can be quite costly. The high expenses make it challenging to obtain treatment, especially in regions with limited access to healthcare facilities or insurance. Despite progress, issues remain with PKU awareness and early diagnosis among healthcare providers and the public.
Delayed diagnosis negatively impacts patient outcomes and postpones the initiation of treatment, thus impacting phenylketonuria treatment market growth. PKU treatment often requires strict dietary restrictions and frequent monitoring of blood phenylalanine levels. Patients, particularly adults and adolescents, struggle to follow their treatment plans, leading to suboptimal results.
Country-wise Insights
North America is set to hold a phenylketonuria treatment market share of 40.2% in 2024. Due to the growing demand for both essential and non-essential amino acids used in the production of finished proteins and their protein-based constituents, China currently holds a significant share of the East Asia market.
What Contributes to the Rising Demand for PKU Treatment in the United States?
“Increasing Prevalence of PKU and Focus on Advanced PKU Dietary Therapies”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 269.6 Million |
| Growth Rate (2024 to 2034) | 6.5% CAGR |
| Projected Value (2034F) | US$ 508 Million |
In 2024, the United States is projected to dominate North America with an 88.1% market share. Demand for phenylketonuria (PKU) treatment is rising due to its growing prevalence among adults and newborns. The United States leads in adopting PKU dietary therapies, with patients regularly consuming essential and non-essential amino acids from specialized ingredients.
To advance PKU management, intensified research efforts are crucial. Government backing for ongoing clinical studies further bolsters the U.S. market's prominence in PKU therapy.
Will the Well-Developed Healthcare System in Japan Push the Adoption of PKU Treatments?
“Implementation of Comprehensive Screening Protocols and Advancements in Diagnostic Technology”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 14 Million |
| Growth Rate (2024 to 2034) | 8.5% CAGR |
| Projected Value (2034F) | US$ 31 Million |
In Japan, awareness of PKU among healthcare professionals and the public has significantly improved. Enhanced screening programs have led to increased detection of PKU cases, particularly through newborn screening initiatives. Japan boasts a robust healthcare system with advanced diagnostic capabilities and specialized medical care readily available, which is a key phenylketonuria treatment market trend. This infrastructure supports early detection and ongoing management of PKU, driving up demand for treatment options.
Category-wise Insights
Essential and non-essential amino acids are set to account for a 72.5% share of the market in 2024. The adult segment is expected to account for a 53.2% market share in 2024. Based on form, powder & granules are poised to hold a market share of 48.8% in 2024.
Retail pharmacies are estimated to acquire a significant market share of 37.9% in 2024. Powder sachets and ready-to-drink forms are poised to hold a market share of 40% in 2024.
Which Target Customer Segment Accounts for Higher Revenue Streams?
“Enhanced Treatment Adherence among Adults”
| Attribute | Adults |
|---|---|
| Segment Value (2024E) | US$ 405.2 Million |
| Growth Rate (2024 to 2034) | 7.4% CAGR |
| Projected Value (2034F) | US$ 829.5 Million |
While phenylketonuria primarily affects children, it can occasionally manifest later in life as a symptom of common neurological diseases.
- Approved by the United States FDA in 2018 for adult use, Palynziq (pegvaliase-pqpz) is an injectable enzyme therapy developed by BioMarin Pharmaceutical Inc. It is intended for adults with PKU whose blood phenylalanine levels remain uncontrollably high despite current medications.
Adults generally demonstrate better adherence to PKU treatment plans because of maturity, understanding of health implications, and autonomy in healthcare decisions. Moreover, the adult demographic's higher disposable incomes provide an added incentive for adopting PKU treatments.
Why are Retail Pharmacies the Leading Sales Channel for PKU Medications?
“Accessibility, Convenience, and Expanded Product Offerings”
| Attribute | Retail Pharmacies |
|---|---|
| Segment Value (2024E) | US$ 288.6 Million |
| Growth Rate (2024 to 2034) | 37.9% CAGR |
| Projected Value (2034F) | US$ 625.5 Million |
In 2024, retail pharmacies are projected to hold a substantial 37.9% share of the global market. This segment has gained prominence thanks to new treatment modalities and extensive research aimed at enhancing strategies for managing phenylketonuria (PKU).
Retail pharmacies now offer a wide range of accessible treatment options, including both branded and generic formulations. The availability of subsidies on select products further fuels growth in this segment, which is expected to drive overall market expansion in the coming years.
Competitive Landscape
Key players in the phenylketonuria treatment industry are covering a large portion of the target population through digital promotion, which is a noteworthy increasing trend. Major players in the industry also advertise their products at conferences and on prestigious international stages. For those new to the industry, this marketing approach is expected to be very profitable.
- Preclinical data for Jnana Therapeutics' lead program, which could be the first-in-class oral treatment for phenylketonuria (PKU), were presented in July 2022. Information was presented at the Vancouver, Washington, National PKU Alliance Conference in 2022.
- A US$ 50 million Series B financing to advance the lead phenylketonuria program and small molecule pipeline based on the next-generation chemoproteomic platform was closed, according to a statement released by Janana Therapeutics in August 2021.
Fact.MR provides detailed information about the price points of key providers of phenylketonuria treatments positioned across the world, sales growth, production capacity, and speculative technological expansion in this updated market report.
Segmentation of Phenylketonuria Treatment Market Research
-
By PKU Ingredient :
- Essential & Non-Essential Amino Acids
- Glycomacropeptide
-
By Form :
- Powder & Granules
- Tablets & Capsules
- Powder Sachets
- Ready-to-Drink
- Shakes
-
By Targeted Customer :
- Adults
- Pediatrics
- Pregnant Women
-
By Sales Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Hypermarkets & Supermarkets
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. PKU Ingredient
- 6.2. Form
- 6.3. Targeted Customer
- 6.4. Sales Channel
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by PKU Ingredient
- 7.1. Essential & Non-Essential Amino Acids
- 7.2. Glycomacropeptide
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Form
- 8.1. Powder & Granules
- 8.2. Tablets & Capsules
- 8.3. Powder Sachets
- 8.4. Ready-to-Drink
- 8.5. Shakes
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Targeted Customer
- 9.1. Adults
- 9.2. Pediatrics
- 9.3. Pregnant Women
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Sales Channel
- 10.1. Hospital Pharmacies
- 10.2. Retail Pharmacies
- 10.3. Online Pharmacies
- 10.4. Hypermarkets & Supermarkets
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. East Asia
- 11.6. South Asia & Pacific
- 11.7. Middle East & Africa
- 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. Sales Forecast 2024 to 2034 by PKU Ingredient, Form, Targeted Customer, Sales Channel, and Region for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Arla Foods Ingredients Group P/S
- 21.2. Archer Daniels Midland Company
- 21.3. BASF SE
- 21.4. Chr. Hansen
- 21.5. Cargill, Incorporated
- 21.6. Seidler Chemical Co, Inc.
- 21.7. Archer Daniels Midland Company
- 21.8. BASF SE
- 21.9. Chr. Hansen
- 21.10. Cargill, Incorporated
- 21.11. Seidler Chemical Co, Inc.
- 21.12. Nestlé S.A. (Vitaflo International)
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 13: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 14: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 15: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 25: North America Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 26: North America Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 27: North America Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 28: North America Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 29: North America Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 30: North America Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 37: Latin America Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 38: Latin America Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 39: Latin America Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 40: Latin America Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 41: Latin America Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 42: Latin America Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 43: Latin America Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 44: Latin America Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 45: Latin America Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 46: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: Western Europe Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 50: Western Europe Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 51: Western Europe Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 52: Western Europe Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 53: Western Europe Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 54: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 55: Western Europe Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 56: Western Europe Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 57: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 58: Western Europe Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 59: Western Europe Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 60: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 61: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 62: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: Eastern Europe Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 65: Eastern Europe Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 66: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 67: Eastern Europe Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 68: Eastern Europe Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 69: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 70: Eastern Europe Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 71: Eastern Europe Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 72: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 74: Eastern Europe Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 76: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 77: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 78: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 79: East Asia Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 80: East Asia Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 81: East Asia Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 82: East Asia Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 83: East Asia Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 84: East Asia Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 85: East Asia Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 86: East Asia Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 87: East Asia Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 88: East Asia Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 89: East Asia Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 90: East Asia Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 91: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 92: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 93: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 94: South Asia & Pacific Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 95: South Asia & Pacific Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 96: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 97: South Asia & Pacific Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 98: South Asia & Pacific Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 99: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 100: South Asia & Pacific Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 101: South Asia & Pacific Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 102: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 103: South Asia & Pacific Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 104: South Asia & Pacific Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 105: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
Table 106: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 107: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 108: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 109: MEA Market Value (US$ Mn) Analysis, by PKU Ingredient, 2019 to 2023
Table 110: MEA Market Value (US$ Mn) Analysis, by PKU Ingredient, 2024 to 2034
Table 111: MEA Market Value (US$ Mn) Opportunity Analysis, by PKU Ingredient, 2024 to 2034
Table 112: MEA Market Value (US$ Mn) Analysis, by Form, 2019 to 2023
Table 113: MEA Market Value (US$ Mn) Analysis, by Form, 2024 to 2034
Table 114: MEA Market Value (US$ Mn) Opportunity Analysis, by Form, 2024 to 2034
Table 115: MEA Market Value (US$ Mn) Analysis, by Targeted Customer, 2019 to 2023
Table 116: MEA Market Value (US$ Mn) Analysis, by Targeted Customer, 2024 to 2034
Table 117: MEA Market Value (US$ Mn) Opportunity Analysis, by Targeted Customer, 2024 to 2034
Table 118: MEA Market Value (US$ Mn) Analysis, by Sales Channel, 2019 to 2023
Table 119: MEA Market Value (US$ Mn) Analysis, by Sales Channel, 2024 to 2034
Table 120: MEA Market Value (US$ Mn) Opportunity Analysis, by Sales Channel, 2024 to 2034
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Form, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Form, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 17: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 18: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 20: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 21: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 22: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 23: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 24: North America Market Share Analysis by Country, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Form, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Form, 2024 to 2034
Figure 33: North America Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 34: North America Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 36: North America Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 37: North America Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 38: North America Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 39: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 40: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 41: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 42: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 43: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 49: Latin America Market Share and BPS Analysis by Form, 2024 & 2034
Figure 50: Latin America Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 51: Latin America Market Attractiveness Analysis by Form, 2024 to 2034
Figure 52: Latin America Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 53: Latin America Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 54: Latin America Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 55: Latin America Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 56: Latin America Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 57: Latin America Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 58: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 59: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 60: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 61: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 62: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 63: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 64: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Western Europe Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 66: Western Europe Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 67: Western Europe Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 68: Western Europe Market Share and BPS Analysis by Form, 2024 & 2034
Figure 69: Western Europe Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 70: Western Europe Market Attractiveness Analysis by Form, 2024 to 2034
Figure 71: Western Europe Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 72: Western Europe Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 73: Western Europe Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 74: Western Europe Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 75: Western Europe Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 76: Western Europe Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 77: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 78: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 79: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 80: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 81: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 82: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 83: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 84: Eastern Europe Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 85: Eastern Europe Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 86: Eastern Europe Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 87: Eastern Europe Market Share and BPS Analysis by Form, 2024 & 2034
Figure 88: Eastern Europe Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 89: Eastern Europe Market Attractiveness Analysis by Form, 2024 to 2034
Figure 90: Eastern Europe Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 91: Eastern Europe Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 92: Eastern Europe Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 93: Eastern Europe Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 94: Eastern Europe Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 95: Eastern Europe Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 96: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 97: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 98: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 99: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 100: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 101: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 102: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 103: East Asia Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 104: East Asia Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 105: East Asia Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 106: East Asia Market Share and BPS Analysis by Form, 2024 & 2034
Figure 107: East Asia Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 108: East Asia Market Attractiveness Analysis by Form, 2024 to 2034
Figure 109: East Asia Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 110: East Asia Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 111: East Asia Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 112: East Asia Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 113: East Asia Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 114: East Asia Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 115: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 116: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 117: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 118: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 119: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 120: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 121: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 122: South Asia & Pacific Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 123: South Asia & Pacific Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 124: South Asia & Pacific Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 125: South Asia & Pacific Market Share and BPS Analysis by Form, 2024 & 2034
Figure 126: South Asia & Pacific Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 127: South Asia & Pacific Market Attractiveness Analysis by Form, 2024 to 2034
Figure 128: South Asia & Pacific Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 129: South Asia & Pacific Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 130: South Asia & Pacific Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 131: South Asia & Pacific Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 132: South Asia & Pacific Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 133: South Asia & Pacific Market Attractiveness Analysis by Sales Channel, 2024 to 2034
Figure 134: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 135: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 136: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 137: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 138: MEA Market Share Analysis by Country, 2024 & 2034
Figure 139: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 140: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 141: MEA Market Share and BPS Analysis by PKU Ingredient, 2024 & 2034
Figure 142: MEA Market Y-o-Y Growth Projections by PKU Ingredient, 2024 to 2034
Figure 143: MEA Market Attractiveness Analysis by PKU Ingredient, 2024 to 2034
Figure 144: MEA Market Share and BPS Analysis by Form, 2024 & 2034
Figure 145: MEA Market Y-o-Y Growth Projections by Form, 2024 to 2034
Figure 146: MEA Market Attractiveness Analysis by Form, 2024 to 2034
Figure 147: MEA Market Share and BPS Analysis by Targeted Customer, 2024 & 2034
Figure 148: MEA Market Y-o-Y Growth Projections by Targeted Customer, 2024 to 2034
Figure 149: MEA Market Attractiveness Analysis by Targeted Customer, 2024 to 2034
Figure 150: MEA Market Share and BPS Analysis by Sales Channel, 2024 & 2034
Figure 151: MEA Market Y-o-Y Growth Projections by Sales Channel, 2024 to 2034
Figure 152: MEA Market Attractiveness Analysis by Sales Channel, 2024 to 2034
- FAQs -
How big is the phenylketonuria treatment market in 2024?
The global phenylketonuria treatment market is estimated at US$ 761.6 million in 2024.
What is the projected market demand for phenylketonuria treatment for 2034?
The market for phenylketonuria treatment is forecasted to reach US$ 1.62 billion by 2034.
Which country has a huge market for phenylketonuria treatment?
The United States is estimated to reach a market value of US$ 269.6 million in 2024.
What is the projected market size of phenylketonuria treatment in China?
The market in China is forecasted to reach US$ 186 million by the end of 2034.
How much is the estimated revenue from online pharmacies?
Sales from online pharmacies are expected to reach US$ 179.3 million in 2024.
What is the estimated market share of South Korea in East Asia?
South Korea accounts for 18.5% market share in East Asia in 2024.
Who are the leaders in the phenylketonuria treatment market?
BASF SE, Chr. Hansen, and Cargill, Incorporated are some of the key players in the market.
Related Reports
Phenylketonuria Treatment Market